Dr. Jose A. Lavergne, MD

Dr. Lavergne practices at Westland Endoscopy Center in Hialeah, Florida.

Dr. Lavergne's NPI, 1003899212, was assigned on November 22, 2005. Dr. Lavergne graduated from Universidad de Panama Faculty of Medicine in 1987. Dr. Lavergne holds Florida license ME0090103.

Dr. Lavergne's primary practice is Westland Endoscopy Center, at 135 W 49th St, Hialeah, FL 33012. The practice phone is (305) 825-1487.

Dr. Lavergne's primary practice is Westland Endoscopy Center in Hialeah, Florida. Dr. Lavergne is also affiliated with HCA Florida Aventura Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Lavergne to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lavergne practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lavergne's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lavergne is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lavergne is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Lavergne treats.

CMS data shows 109 Medicare services from Dr. Lavergne across 5 procedure codes in 2024, for 83 Medicare patients. Medicare paid $12,237 for them.

CMS counts 83 Medicare patients who saw Dr. Lavergne in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lavergne's median patient age at 60, with 58% women.

In 2024, Dr. Lavergne wrote 2,242 Medicare Part D claims for 964 patients. 62% of them were for generic drugs. CMS names the drug for 2,017 of them, across 35 drugs with 11 or more claims each, at $1,105,949 in total drug cost. In 2023, CMS named 2,084 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Lavergne for performance year 2024, reported as part of a group. Dr. Lavergne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of colonoscopy by Dr. Lavergne, more than 45% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 211 general payments to Dr. Lavergne from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $925.

Dmand AI lists 3 awards for Dr. Lavergne, most recently CMS Stage 1 2012 in 2011.

Dr. Lavergne graduated from Universidad de Panama Faculty of Medicine in 1987.

Dr. Lavergne is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.